San Francisco and its hotel industry are partnering to beef up security around this week's 43rd annual J.P. Morgan Healthcare ...

Industry leaders from more than 500 companies scheduled to give investor presentations will see heightened security ...

According to JP Morgan, U.S. large-cap biopharma stocks have underperformed the broader market for two consecutive years, ...

Erin Whaley, Tammy Ward Woffenden and Paul M. Mahoney Jr. of Troutman Pepper Locke LLP discuss key market and legal ...

AdventHealth and Novant Health have set $30 billion annual revenue targets, fueled by a growing demand for care and interest ...

Welcome to the Novartis presentation at the 43rd JPMorgan Healthcare Conference. I'm Richard Vosser, European pharma analyst with JPMorgan. It's my great pleasure to introduce Vas Narasimhan, the CEO ...

Since society rebounded from the pandemic, Teladoc Health has gone from a soaring rocket ship considered an emblem of the ...

As the healthcare and life sciences industry gears up for the highly anticipated JP Morgan Healthcare Conference later this ...

The team has already launched coverage on fifteen biotechnology companies, including emerging players in cell therapy, oncology, immunology and more. This initial coverage reflects Clear Street's ...

J.P. Morgan Healthcare Conference is officially underway, bringing the healthcare and biopharma industries' biggest wheelers ...

JPMorgan Chase formed Morgan Health from the ashes of Haven, its scuttled healthcare collaboration with Amazon and Berkshire ...